Toronto Innovation Acceleration Partners (TIAP) is a biotechnology research and venture building organization headquartered in Toronto, Ontario, Canada. The firm specializes in commercializing early-stage health science technologies originating from academic research members.
Subscribe to see TIAP’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
TIAP is a biotechnology company headquartered in Canada. Xcout tracks 12 named people at TIAP, including Dr. Andy J. Smith (President & CEO, Sunnybrook Health Sciences Centre).
6 more named people on record for TIAP, with roles, board committees and tenure — see the full roster →
A few of TIAP's closest competitors — see the full list of competitors and alternatives →
Arch Biopartners Inc. is a biotechnology firm dedicated to devising groundbreaking solutions for both medical and commercial applications. A significant focus for the company is the advancement of Metablok, a key therapeutic agent designed to address or avert dipeptidase-1 driven inflammation in critical organs such as the lungs, liver, and kidneys. This inflammatory response can lead to profound organ dysfunction or complete failure, particularly in conditions like sepsis and COVID-19. Moreover, Arch Biopartners is developing AB569, an experimental medication intended to combat antibiotic-resistant bacterial infections, primarily through topical application on wounds. Their innovative product pipeline also features Borg, a specialized peptide-solid surface interface developed to hinder biofilm formation and lessen material corrosion. Lastly, MetaMx involves synthetic compounds engineered to target the cells that initiate brain tumors and invasive glioma cells. The company's operations are based out of Toronto, Canada.
BioMotiv is a Cleveland-based biotechnology company that develops and commercializes promising biomedical discoveries, particularly therapeutics, emerging from academic and research institutions. It partners with scientists, universities, and investors to form and support companies advancing these discoveries toward clinical development.
Deep Genomics is a biotechnology research company that collaborates across disciplines to solve complex molecular design challenges. The company's corporate headquarters are located in Toronto, Ontario, Canada, a hub for innovation.
AdMare BioInnovations serves as Canada's life sciences company creation engine, offering turnkey lab, office, and collaboration facilities through its Innovation Centres.
Acorn Biolabs is a biotechnology company headquartered in Toronto, Ontario, that specializes in personalized regenerative medicine. The company provides non-invasive live cell collection, cryopreservation, and analytical services.
Accelerator Life Science Partners is a life-sciences venture capital and company-creation firm that invests in and helps build early-stage biotechnology, medical device, and related healthcare companies. It works with scientists, entrepreneurs, and other investors to develop and commercialize new technologies.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.